Gentle touch: acupressure tested for newborn jaundice
NCT ID NCT07409194
First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 2 times
Summary
This study tests whether gentle acupressure on specific points can lower bilirubin levels in full-term newborns with jaundice. Sixty babies will be randomly assigned to receive acupressure or standard care. The goal is to see if this simple, non-invasive technique can help reduce jaundice severity.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- acupressure
- What this could lead to
- If it works, acupressure could become a simple, drug-free way to help manage newborn jaundice alongside standard care.
- What could go wrong
- This is a very small, early trial with only 60 babies. The effect may be small or not work at all, and results may not apply to all newborns.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
38 weeks to 42 months
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Gestational age ≥38 weeks * Diagnosed with neonatal hyperbilirubinemia * Hospitalized in the neonatal unit for at least 24 hours * Birth weight ≥2500 g * Written informed consent obtained from parents Exclusion Criteria: * Preterm newborns * Congenital metabolic disease or congenital anomalies * Hemodynamically unstable newborns * Newborns whose parents did not provide consent * Newborns with any condition preventing acupressure application
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hyperbilirubinemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Van Yuzuncu Yil University
Van, 65100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.